β− Arrestins: structure, function, physiology, and pharmacological perspectives

J Wess, AB Oteng, O Rivera-Gonzalez… - Pharmacological …, 2023 - ASPET
The two β-arrestins, β-arrestin-1 and-2 (systematic names: arrestin-2 and-3, respectively),
are multifunctional intracellular proteins that regulate the activity of a very large number of …

[HTML][HTML] BRAF V600-mutated metastatic melanoma and targeted therapy resistance: an update of the current knowledge

L Florent, C Saby, F Slimano, H Morjani - Cancers, 2023 - mdpi.com
Simple Summary Metastatic melanoma is the most lethal skin cancer due to its high
metastatic potential and resistance to treatment. The advent of targeted therapies has …

[HTML][HTML] Current insights and progress in the clinical management of head and neck cancer

MN Amaral, P Faísca, HA Ferreira, MM Gaspar… - Cancers, 2022 - mdpi.com
Simple Summary Head and neck cancer (HNC) incidence has been steadily increasing
since the 1990s. While the multimodal treatment approach for localized HNC is well …

[HTML][HTML] Current treatment of melanoma brain metastases

A Nowacka, A Fajkiel-Madajczyk, J Ohla… - Cancers, 2023 - mdpi.com
Simple Summary Melanoma has the highest mortality rate of all skin cancers and its
prognosis is worsened by metastasis to the brain. Before discovering new treatments for …

[HTML][HTML] Determination of some isoquinoline alkaloids in extracts obtained from selected plants of the Ranunculaceae, Papaveraceae and Fumarioideae families by …

J Misiurek, T Plech, B Kaproń, A Makuch-Kocka… - Molecules, 2023 - mdpi.com
Alkaloids are heterocyclic bases with widespread occurrence in nature. Plants are rich and
easily accessible sources of them. Most isoquinoline alkaloids have cytotoxic activity for …

[HTML][HTML] Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis

JN Priantti, M Vilbert, T Madeira, FCA Moraes… - Cancers, 2023 - mdpi.com
Simple Summary Approximately 50% of patients with melanoma harbor a BRAF mutation
and are eligible for targeted therapy with BRAF/MEK inhibitors (BRAFi/MEKi). Despite a …

[HTML][HTML] Photodynamic Activity of TMPyP4/TiO2 Complex under Blue Light in Human Melanoma Cells: Potential for Cancer-Selective Therapy

M Balas, S Nistorescu, MA Badea, A Dinischiotu… - Pharmaceutics, 2023 - mdpi.com
The combination of TiO2 nanoparticles (NPs) and photosensitizers (PS) may offer significant
advantages in photodynamic therapy (PDT) of melanoma, such as improved cell …

[HTML][HTML] A review of advanced cutaneous melanoma therapies and their mechanisms, from immunotherapies to lysine histone methyl transferase inhibitors

RS de Oliveira Filho, DA de Oliveira, MM Nisimoto… - Cancers, 2023 - mdpi.com
Simple Summary Advanced cutaneous melanoma is the most aggressive type of skin cancer
and has variable rates of treatment response. Currently, there are some classes of …

[HTML][HTML] Pterostilbene-mediated inhibition of cell proliferation and cell death induction in amelanotic and melanotic melanoma

J Wawszczyk, K Jesse, M Kapral - International Journal of Molecular …, 2023 - mdpi.com
Melanoma is one of the fastest-growing cancers worldwide. Treatment of advanced
melanoma is very difficult; therefore, there is growing interest in the identification of new …

[HTML][HTML] Daphnetin, a coumarin with anticancer potential against human melanoma: in vitro study of its effective combination with selected cytostatic drugs

P Wróblewska-Łuczka, A Góralczyk, JJ Łuszczki - Cells, 2023 - mdpi.com
(1) The treatment of metastatic or drug-resistant melanoma is still a significant therapeutic
problem. The aim of this study was to evaluate the anticancer potential of daphnetin (7, 8 …